本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eagle製藥

0.1500
+0.065076.47%
成交量:3,061.00
成交額:273.90
市值:195.35萬
市盈率:0.16
高:0.1500
開:0.0850
低:0.0850
收:0.0850
52周最高:3.87
52周最低:0.0011
股本:1,302.31萬
流通股本:631.13萬
量比:11.40
換手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):0.9117
每股收益(LYR):2.73
淨資產收益率:4.88%
總資產收益率:6.63%
市淨率:0.01
市盈率(LYR):0.05

資料載入中...

2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

重要事件披露

Form 8-K - Current report
2024/11/26

自願退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/05

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/10/09

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/02

重要事件披露

Form 8-K - Current report
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/05

重要事件披露

Form 8-K - Current report